“…The term "nanomedicine" thus comprises formulations in the nanometer scale (i.e., nanoformulations) composed of organic materials such as lipids or polymers, or inorganic materials such as metals, that can be used to deliver small molecules or biomolecules, namely proteins, peptides or nucleic acids. Nanomedicine can be used for therapeutic purposes [41], but it also has an application in diagnostics and regenerative medicine [42] With respect to the specific application of nanomedicine in gene delivery, all the research performed in the last 30 years has resulted in safe and effective delivery platforms for nucleic acids, such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNA), DNA and more recently mRNA, using different types of strategies such as Gal-NAc conjugates, and different delivery vehicles such as Adeno-Associated Virus (AAD) and more recently LNPs, as recently reviewed in this article [43]. Despite this great effort, at present there is only one nanoformulation in the market for siRNA delivery, Onpattro ® ; however, many others are undergoing clinical trials, and more genetic nanomedicines are expected to be seen in the near future [43].…”